DIVIS LAB Q4 : Net Profit up 29 % to Rs 502 cr (YOY)
Revneue Up 28 % to Rs 1788 cr
Revneue Up 28 % to Rs 1788 cr
Dividend Updates
👉🏻Kovilpatti Lakshmi Roller Flour Mills Ltd board recommends dividend of Rs. 1.50
👉🏻Lakshmi Electrical Control Systems Ltd board recommends dividend of Rs. 3.50
👉🏻NESCO Ltd board recommends final dividend of Rs. 3
👉🏻NCC Limited Board recommends Dividend of Rs. 0.80
👉🏻Dilip Buildcon Limited board recommends dividend of Rs. 1
👉🏻Indian Bank board recommends dividend of Rs. 2 for FY21
👉🏻Action Construction Equipment Ltd Board recommends Dividend of Rs. 0.50
👉🏻Deepak Fertilisers and Petrochemicals Corporation Limited Board approves Dividend of Rs. 7.50
👉🏻Permanent Magnets Ltd board recommends dividend of Rs. 1
👉🏻ITD CEMENTATION Rs. 0.12
👉🏻Rama Phosphates Ltd Board recommends Final Dividend of Rs. 1
👉🏻TV Today Network Ltd Board recommends Final Dividend of Rs. 2.50
👉🏻Mahindra & Mahindra Ltd Board approves dividend of Rs. 8.75
👉🏻Rajapalayam Mills Ltd Board approves dividend of Rs. 0.50
👉🏻Pudumjee Paper Products Ltd Board approves dividend of Rs. 0.30
👉🏻Kovilpatti Lakshmi Roller Flour Mills Ltd board recommends dividend of Rs. 1.50
👉🏻Lakshmi Electrical Control Systems Ltd board recommends dividend of Rs. 3.50
👉🏻NESCO Ltd board recommends final dividend of Rs. 3
👉🏻NCC Limited Board recommends Dividend of Rs. 0.80
👉🏻Dilip Buildcon Limited board recommends dividend of Rs. 1
👉🏻Indian Bank board recommends dividend of Rs. 2 for FY21
👉🏻Action Construction Equipment Ltd Board recommends Dividend of Rs. 0.50
👉🏻Deepak Fertilisers and Petrochemicals Corporation Limited Board approves Dividend of Rs. 7.50
👉🏻Permanent Magnets Ltd board recommends dividend of Rs. 1
👉🏻ITD CEMENTATION Rs. 0.12
👉🏻Rama Phosphates Ltd Board recommends Final Dividend of Rs. 1
👉🏻TV Today Network Ltd Board recommends Final Dividend of Rs. 2.50
👉🏻Mahindra & Mahindra Ltd Board approves dividend of Rs. 8.75
👉🏻Rajapalayam Mills Ltd Board approves dividend of Rs. 0.50
👉🏻Pudumjee Paper Products Ltd Board approves dividend of Rs. 0.30
Itc has announced the board meeting for considering the q4 21 and fy 21 results alongwith dividend on 1st june 2021. Grapewine says ITC will announce liberal bonus and tripple de merger on 1st june. De merger of cigg , hotel and fmcg is almost certain only timing was the concern snd now sources says this will be done on 1st june.
BAT has formally submitted a proposal to the Govt of India to buy out the SUUTII stake in ITC. However wven though cig is not strategic for Govt they have not yet decided to sell this stake either to BAT or LIC but in order to meet the financial challenges the stake sell will happen in this calender year. Govt already sold Axis. Only ITC and Larsen remained and both will happen in next 3 months as per sources.
Itc set to announce the best quarter nos i. Q. It will beat the estimste by margins. Itc will report Rs 13770 ( estimate rs 13000 crs ) crs revenue as ag Rs 12491 crs for qoq and Rs 11300 yoy. The ibitda will be Rs 6000 crs ( estimates rs 5333 crs )as ag Rs 5250 crs qoq and Rs 4919 crs for yoy.
There is considerable amount of pessimishm from ITC and there is no expectation from the company. However we raise the target of ITC to Rs 300 in june .
HOS
BAT has formally submitted a proposal to the Govt of India to buy out the SUUTII stake in ITC. However wven though cig is not strategic for Govt they have not yet decided to sell this stake either to BAT or LIC but in order to meet the financial challenges the stake sell will happen in this calender year. Govt already sold Axis. Only ITC and Larsen remained and both will happen in next 3 months as per sources.
Itc set to announce the best quarter nos i. Q. It will beat the estimste by margins. Itc will report Rs 13770 ( estimate rs 13000 crs ) crs revenue as ag Rs 12491 crs for qoq and Rs 11300 yoy. The ibitda will be Rs 6000 crs ( estimates rs 5333 crs )as ag Rs 5250 crs qoq and Rs 4919 crs for yoy.
There is considerable amount of pessimishm from ITC and there is no expectation from the company. However we raise the target of ITC to Rs 300 in june .
HOS
*Dhanlaxmi Bank Ltd.* | *CMP* Rs. 15 | *M Cap* Rs. 382 Cr | *52 W H/L* 18/9
(Nirmal Bang Retail Research)
*Result is declining*
Net Interest Income came at Rs. 71.3 Cr vs YoY Rs. 85.5 Cr, QoQ Rs. 90.7 Cr
Non Interest Income came at Rs. 29.4 Cr vs YoY Rs. 38.1 Cr, QoQ Rs. 48.9 Cr
PBP came at Rs. -4.1 Cr vs YoY Rs. 39.8 Cr, QoQ Rs. 32.2 Cr
Provisions came at Rs. -14.8 Cr vs YoY Rs. 56.9 Cr, QoQ Rs. 20.4 Cr
Adj. PAT came at Rs. 5.3 Cr vs YoY Rs. 2.6 Cr, QoQ Rs. 11.8 Cr
Gross NPA came at Rs. 657.2 Cr vs QoQ (non-proforma) Rs. 395 Cr at 9.23% vs QoQ 5.78%
Net NPA came at Rs. 322.9 Cr vs QoQ (non-proforma) Rs. 72.4 Cr at 4.76% vs QoQ 1.11%
Quarter EPS is Rs. 0.2
Share is trading at P/E of 0x FY22E EPS & 0.7x trailing P/Adj. BV
(Nirmal Bang Retail Research)
*Result is declining*
Net Interest Income came at Rs. 71.3 Cr vs YoY Rs. 85.5 Cr, QoQ Rs. 90.7 Cr
Non Interest Income came at Rs. 29.4 Cr vs YoY Rs. 38.1 Cr, QoQ Rs. 48.9 Cr
PBP came at Rs. -4.1 Cr vs YoY Rs. 39.8 Cr, QoQ Rs. 32.2 Cr
Provisions came at Rs. -14.8 Cr vs YoY Rs. 56.9 Cr, QoQ Rs. 20.4 Cr
Adj. PAT came at Rs. 5.3 Cr vs YoY Rs. 2.6 Cr, QoQ Rs. 11.8 Cr
Gross NPA came at Rs. 657.2 Cr vs QoQ (non-proforma) Rs. 395 Cr at 9.23% vs QoQ 5.78%
Net NPA came at Rs. 322.9 Cr vs QoQ (non-proforma) Rs. 72.4 Cr at 4.76% vs QoQ 1.11%
Quarter EPS is Rs. 0.2
Share is trading at P/E of 0x FY22E EPS & 0.7x trailing P/Adj. BV
*MONEY TIMES TALK*
_May 29, 2021_
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
_May 29, 2021_
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
*Jayant Organics’* Q4 EPS was fairly good at Rs. 6.48 v/s Rs. 2.52 and FY21 EPS of Rs. 11.20 v/s loss of Rs. 8.55 per share points to much better times ahead. Add.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Jindal SAW* declared highest ever quarterly sales and 461% higher net profit. It reduced debt in FY21 and interest cost fell to the lowest since FY14. This dark horse can give multi-bagger returns.
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 200 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 200 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
🎯 Join us 🎯
📢 If stock markets excite you, install Telegram app on your mobile/desktop and join our two Telegram Channels
➡️ @TELEGRAM
➡️https://t.me/marketswizard
👆 *Learning and earning group*
➡️https://t.me/BooksMakeIndiaRead
👆 *Knowledge Enhancement Group*
➡️ @FACEBOOK
https://www.facebook.com/groups/477543072412657/?ref=share
👆 *You can follow us on Facebook also*
➡️ @TWITTER
You can follow us at (@shrey9341): https://twitter.com/shrey9341?s=09
👆 *You can follow us on Twitter also*
📢 If stock markets excite you, install Telegram app on your mobile/desktop and join our two Telegram Channels
➡️ @TELEGRAM
➡️https://t.me/marketswizard
👆 *Learning and earning group*
➡️https://t.me/BooksMakeIndiaRead
👆 *Knowledge Enhancement Group*
➡️ @FACEBOOK
https://www.facebook.com/groups/477543072412657/?ref=share
👆 *You can follow us on Facebook also*
➡️ @TWITTER
You can follow us at (@shrey9341): https://twitter.com/shrey9341?s=09
👆 *You can follow us on Twitter also*
Telegram
Market Wizard
FREE FINANCIAL EDUCATIONAL CHANNEL
Disclaimer : We are not SEBI Registered. Please consult your financial advisor before investing.
All the posts appearing in the channel are only for educational and informational purposes.
ALL RIGHTS RESERVED!!!
Disclaimer : We are not SEBI Registered. Please consult your financial advisor before investing.
All the posts appearing in the channel are only for educational and informational purposes.
ALL RIGHTS RESERVED!!!
🎯🎯🎯
📢 MARKET WIZARD QUARTERLY / YEARLY SUBSCRIPTION PLAN
📢 WE PROVIDE EQUITY CASH AND F&O ALL UNDER ONE PLAN
✒️ 1000/MONTHLY
✒️ 3000/3MONTH
✒️ 10000/YEARLY
🎯 FOLLOWING TYPES OF CALLS WILL BE GIVEN HERE
🚀 INTRADAY
🚀 SHORT TERM & MEDIUM TERM
🚀 POSITIONAL
🚀 LONG TERM OR DELIVERY
🚀 FUTURES & OPTIONS
🚀 SIP STOCKS
🚀 BTST CALLS
📢 CALLS WILL BE FROM MARKET CAPS
👉 LARGE CAP
👉 MID CAP
👉 SMALL CAP
🎯 ALL SEGMENT'S RECCOMONDATION IN ONE ROOF
🎯 MANDETORY TO ALL WHO WANT AVAIL SUBSCRIPTION FILL BELOW FORM AND SUBMIT IT
https://docs.google.com/forms/d/e/1FAIpQLSed5g8JiIGlttu3IUlkJwnCdEMzv-1Z_hr3ylfU55pepmCb6A/viewform?usp=sf_link
👉 TO AVAIL THIS SUBSCRIPTION & MORE DETAILS.
📢 CONTACT BELOW
➡️ Jimit Parekh Sir : +91 9821722433
➡️ Darpan Solanki Sir : +91 9924832776
➡️ Divesh Jain Sir: +91 9870736813
☑️ NOTE :- ENTRY AND EXIT SHOULD BE TAKEN BY MEMBERS CHOICE
⛔ DISCLAIMER :-
WE ARE NOT SEBI REGISTERED
⛔ TRADE AT UR OWN RISK
📢 MARKET WIZARD QUARTERLY / YEARLY SUBSCRIPTION PLAN
📢 WE PROVIDE EQUITY CASH AND F&O ALL UNDER ONE PLAN
✒️ 1000/MONTHLY
✒️ 3000/3MONTH
✒️ 10000/YEARLY
🎯 FOLLOWING TYPES OF CALLS WILL BE GIVEN HERE
🚀 INTRADAY
🚀 SHORT TERM & MEDIUM TERM
🚀 POSITIONAL
🚀 LONG TERM OR DELIVERY
🚀 FUTURES & OPTIONS
🚀 SIP STOCKS
🚀 BTST CALLS
📢 CALLS WILL BE FROM MARKET CAPS
👉 LARGE CAP
👉 MID CAP
👉 SMALL CAP
🎯 ALL SEGMENT'S RECCOMONDATION IN ONE ROOF
🎯 MANDETORY TO ALL WHO WANT AVAIL SUBSCRIPTION FILL BELOW FORM AND SUBMIT IT
https://docs.google.com/forms/d/e/1FAIpQLSed5g8JiIGlttu3IUlkJwnCdEMzv-1Z_hr3ylfU55pepmCb6A/viewform?usp=sf_link
👉 TO AVAIL THIS SUBSCRIPTION & MORE DETAILS.
📢 CONTACT BELOW
➡️ Jimit Parekh Sir : +91 9821722433
➡️ Darpan Solanki Sir : +91 9924832776
➡️ Divesh Jain Sir: +91 9870736813
☑️ NOTE :- ENTRY AND EXIT SHOULD BE TAKEN BY MEMBERS CHOICE
⛔ DISCLAIMER :-
WE ARE NOT SEBI REGISTERED
⛔ TRADE AT UR OWN RISK
Google Docs
MARKET WIZARD PREMIUM
🔴Rules & Disclaimers
📢PLS READ IT VERY CAREFULLY BEFORE AGREEING
1️⃣No phone calls or personal message to the admins.
2️⃣No chit-chat shall be entertained in the group.
3️⃣No sure shot on any views.
4️⃣Profit / loss not guaranteed.
5️⃣Those who want…
📢PLS READ IT VERY CAREFULLY BEFORE AGREEING
1️⃣No phone calls or personal message to the admins.
2️⃣No chit-chat shall be entertained in the group.
3️⃣No sure shot on any views.
4️⃣Profit / loss not guaranteed.
5️⃣Those who want…
MARKET WIZARD NEWSLETTER ISSUE 12.pdf
2 MB
MARKET WIZARD NEWSLETTER ISSUE 12.pdf
🎯MARKET WIZARD🎯
📊 NEWSLETTER ISSUE 12
🎯 *Fundamental Stocks*
▶️Nelcast Ltd
▶️D B Corp Ltd
▶️Reliance Industries Ltd
▶️ITC Industrial Ltd
▶️BCG Ltd
🎯 *Technical Stocks*
▶️Arvind Fashion Ltd
▶️ *BBTC Ltd - SPECIAL PICK*
▶️ INTENSE TECH Ltd
▶️ KIRI INDUSTRIES Ltd
▶️ TOKYO PLAST Ltd
📍TEAM MARKET WIZARD📍
📊 NEWSLETTER ISSUE 12
🎯 *Fundamental Stocks*
▶️Nelcast Ltd
▶️D B Corp Ltd
▶️Reliance Industries Ltd
▶️ITC Industrial Ltd
▶️BCG Ltd
🎯 *Technical Stocks*
▶️Arvind Fashion Ltd
▶️ *BBTC Ltd - SPECIAL PICK*
▶️ INTENSE TECH Ltd
▶️ KIRI INDUSTRIES Ltd
▶️ TOKYO PLAST Ltd
📍TEAM MARKET WIZARD📍
Good Afternoon Members
Market Wizard is trying to help each of our members... Whether Premium Members or Public Members and we aim at solving queries of everyone
However, members are failing to understand that an admin has to respond to more than 10000 members and they do have some personal life and personal work
It is observed that members are expecting spoon feeding for each call given... message are being sent in Personal for entry and exit despite everything mentioned in the calls
It is also observed that when the Admin do not respond to the queries for sometime, continuous calls are being made
Members have been calling and asking the admin to send the Newsletter to them personally or send them every week to their email id.
Members please understand...Stop Calling us for everything...We can't do spoon feeding.You all are in stock market and putting in your hard earned money...so please put some efforts and don't expect spoon feeding
If such calls keep on flowing continuously, that member shall be removed from the group, even if he is a Premium Members
Market Wizard is trying to help each of our members... Whether Premium Members or Public Members and we aim at solving queries of everyone
However, members are failing to understand that an admin has to respond to more than 10000 members and they do have some personal life and personal work
It is observed that members are expecting spoon feeding for each call given... message are being sent in Personal for entry and exit despite everything mentioned in the calls
It is also observed that when the Admin do not respond to the queries for sometime, continuous calls are being made
Members have been calling and asking the admin to send the Newsletter to them personally or send them every week to their email id.
Members please understand...Stop Calling us for everything...We can't do spoon feeding.You all are in stock market and putting in your hard earned money...so please put some efforts and don't expect spoon feeding
If such calls keep on flowing continuously, that member shall be removed from the group, even if he is a Premium Members
Follow this link to join my WhatsApp group: https://chat.whatsapp.com/KUuI70RifSW7chXFiwwAMY
Result Highlights
Mahindra & Mahindra Ltd.: Net Revenue at Rs. 21456.0 crore, +31.5% YoY and -0.8% QoQ. EBITDA at Rs. 3884.3 crore, +41.6% YoY and +10.3% QoQ. EBITDA Margin at 18.1%, +129 bps YoY and +182 bps QoQ. Net Profit at Rs. 1634.9 crore vs loss of Rs. 588.1 crore YoY and +41.2% QoQ.
3M India Ltd.: Net Revenue at Rs. 827.1 crore, +22.9% YoY and +11.5% QoQ. EBITDA at Rs. 102.3 crore, +34% YoY and +11.6% QoQ. EBITDA Margin at 12.4%, +103 bps YoY and +1 bps QoQ. Net Profit at Rs. 70.5 crore, +17.2% YoY and +18.7% QoQ.
Sundaram Finance Ltd.: Net Revenue at Rs. 1285.0 crore, -2.7% YoY and -7.7% QoQ. Net Profit at Rs. 299.4 crore, +38.8% YoY and -17.7% QoQ.
REC Ltd.: Net Revenue at Rs. 9211.5 crore, +19.3% YoY and +1.4% QoQ. Net Profit at Rs. 2077.8 crore, +338.4% YoY and -8% QoQ.
Ipca Laboratories Ltd.: Net Revenue at Rs. 1114.7 crore, +3.8% YoY and -20.9% QoQ. EBITDA at Rs. 228.9 crore, +35.9% YoY and -37.6% QoQ. EBITDA Margin at 20.5%, +485 bps YoY and +-549 bps QoQ. Net Profit at Rs. 161.2 crore, +94.1% YoY and -39.8% QoQ.
Max Healthcare Institute Ltd.: Net Revenue at Rs. 801.9 crore, +223.5% YoY and +0.8% QoQ. EBITDA at Rs. 168.1 crore, +754.9% YoY and +5% QoQ. EBITDA Margin at 21%, +1303 bps YoY and +83 bps QoQ. Net Profit at Rs. 69.7 crore, +31.1% YoY and -22.9% QoQ.
Sumitomo Chemical India Ltd.: Net Revenue at Rs. 534.3 crore, +19.6% YoY and -4.7% QoQ. EBITDA at Rs. 71.3 crore, +72.2% YoY and -8.6% QoQ. EBITDA Margin at 13.4%, +408 bps YoY and +-56 bps QoQ. Net Profit at Rs. 54.1 crore, +136.2% YoY and -0.1% QoQ.
Glenmark Pharmaceuticals Ltd.: Net Revenue at Rs. 2859.9 crore, +3.3% YoY and +2.6% QoQ. EBITDA at Rs. 523.4 crore, +12.4% YoY and -1.3% QoQ. EBITDA Margin at 18.3%, +147 bps YoY and +-72 bps QoQ. Net Profit at Rs. 233.9 crore, +6.2% YoY and -5.8% QoQ.
Indian Bank: NII at Rs. 3334.3 crore, +66.5% YoY and -22.7% QoQ. Net Profit at Rs. 1708.9 crore vs loss of Rs. 217.4 crore YoY and +232.3% QoQ. GNPA at 9.85%, Vs 6.87% YoY and 9.04% QoQ. NNPA at 3.37%, Vs 3.13% YoY and 2.35% QoQ.
City Union Bank Ltd.: NII at Rs. 428.5 crore, +2.2% YoY and -12.4% QoQ. Net Profit at Rs. 111.2 crore vs loss of Rs. 95.3 crore YoY and -34.6% QoQ. GNPA at 5.11x, Vs 4.09x YoY and 2.94x QoQ. NNPA at 2.97x, Vs 2.29x YoY and 1.47x QoQ.
Dilip Buildcon Ltd.: Net Revenue at Rs. 3135.5 crore, +14.9% YoY and +14.2% QoQ. EBITDA at Rs. 584.3 crore, +0.5% YoY and -7.3% QoQ. EBITDA Margin at 18.6%, -266 bps YoY and -432 bps QoQ. Net Profit at Rs. 186.2 crore, -2.6% YoY and +2.2% QoQ.
GMM Pfaudler Ltd.: Net Revenue at Rs. 458.6 crore, +248% YoY and +127.2% QoQ. EBITDA at Rs. 29.8 crore, +32.5% YoY and -29% QoQ. EBITDA Margin at 6.5%, -1056 bps YoY and -1429 bps QoQ. Net Profit at Rs. -5.8 crore, -149.6% YoY and -124.9% QoQ.
V-Mart Retail Ltd.: Net Revenue at Rs. 351.9 crore, +5.8% YoY and -25.1% QoQ. EBITDA at Rs. 33.6 crore, +20.5% YoY and -67.7% QoQ. EBITDA Margin at 9.5%, +117 bps YoY and +-1255 bps QoQ. Net Loss at Rs. 1.5 crore vs loss of Rs. 8.4 crore YoY and Profit of Rs. 47.9 crore QoQ.
Heidelberg Cement India Ltd.: Net Revenue at Rs. 600.0 crore, +17.7% YoY and +0.8% QoQ. EBITDA at Rs. 152.2 crore, +19.5% YoY and +26.6% QoQ. EBITDA Margin at 25.4%, +38 bps YoY and +517 bps QoQ. Net Profit at Rs. 140.0 crore, +111.2% YoY and +120% QoQ.
Nazara Technologies Ltd.: Net Revenue at Rs. 123.4 crore, +41.7% YoY and -5.4% QoQ. EBITDA at Rs. 9.3 crore, +1883.2% YoY and -63.6% QoQ. EBITDA Margin at 7.6%, +701 bps YoY and +-1209 bps QoQ. Net Profit at Rs. 4.2 crore vs loss of Rs. 7.0 crore YoY and -76.3% QoQ.
NCC Ltd.: Net Revenue at Rs. 2816.6 crore, +20.7% YoY and +32.4% QoQ. EBITDA at Rs. 305.7 crore, +6.5% YoY and +19.3% QoQ. EBITDA Margin at 10.9%, -144 bps YoY and -119 bps QoQ. Net Profit at Rs. 118.5 crore, +95.6% YoY and +52.1% QoQ.
Karur Vysya Bank Ltd.: NII at Rs. 612.6 crore, +3.7% YoY and +5% QoQ. Net Profit at Rs. 104.4 crore, +24.7% YoY and +201.4% QoQ. GNPA at 7.85x, Vs 8.68x YoY and 7.37x QoQ. NNPA at 3.41x, Vs 3.92x YoY and 2.55x QoQ.
Mahindra & Mahindra Ltd.: Net Revenue at Rs. 21456.0 crore, +31.5% YoY and -0.8% QoQ. EBITDA at Rs. 3884.3 crore, +41.6% YoY and +10.3% QoQ. EBITDA Margin at 18.1%, +129 bps YoY and +182 bps QoQ. Net Profit at Rs. 1634.9 crore vs loss of Rs. 588.1 crore YoY and +41.2% QoQ.
3M India Ltd.: Net Revenue at Rs. 827.1 crore, +22.9% YoY and +11.5% QoQ. EBITDA at Rs. 102.3 crore, +34% YoY and +11.6% QoQ. EBITDA Margin at 12.4%, +103 bps YoY and +1 bps QoQ. Net Profit at Rs. 70.5 crore, +17.2% YoY and +18.7% QoQ.
Sundaram Finance Ltd.: Net Revenue at Rs. 1285.0 crore, -2.7% YoY and -7.7% QoQ. Net Profit at Rs. 299.4 crore, +38.8% YoY and -17.7% QoQ.
REC Ltd.: Net Revenue at Rs. 9211.5 crore, +19.3% YoY and +1.4% QoQ. Net Profit at Rs. 2077.8 crore, +338.4% YoY and -8% QoQ.
Ipca Laboratories Ltd.: Net Revenue at Rs. 1114.7 crore, +3.8% YoY and -20.9% QoQ. EBITDA at Rs. 228.9 crore, +35.9% YoY and -37.6% QoQ. EBITDA Margin at 20.5%, +485 bps YoY and +-549 bps QoQ. Net Profit at Rs. 161.2 crore, +94.1% YoY and -39.8% QoQ.
Max Healthcare Institute Ltd.: Net Revenue at Rs. 801.9 crore, +223.5% YoY and +0.8% QoQ. EBITDA at Rs. 168.1 crore, +754.9% YoY and +5% QoQ. EBITDA Margin at 21%, +1303 bps YoY and +83 bps QoQ. Net Profit at Rs. 69.7 crore, +31.1% YoY and -22.9% QoQ.
Sumitomo Chemical India Ltd.: Net Revenue at Rs. 534.3 crore, +19.6% YoY and -4.7% QoQ. EBITDA at Rs. 71.3 crore, +72.2% YoY and -8.6% QoQ. EBITDA Margin at 13.4%, +408 bps YoY and +-56 bps QoQ. Net Profit at Rs. 54.1 crore, +136.2% YoY and -0.1% QoQ.
Glenmark Pharmaceuticals Ltd.: Net Revenue at Rs. 2859.9 crore, +3.3% YoY and +2.6% QoQ. EBITDA at Rs. 523.4 crore, +12.4% YoY and -1.3% QoQ. EBITDA Margin at 18.3%, +147 bps YoY and +-72 bps QoQ. Net Profit at Rs. 233.9 crore, +6.2% YoY and -5.8% QoQ.
Indian Bank: NII at Rs. 3334.3 crore, +66.5% YoY and -22.7% QoQ. Net Profit at Rs. 1708.9 crore vs loss of Rs. 217.4 crore YoY and +232.3% QoQ. GNPA at 9.85%, Vs 6.87% YoY and 9.04% QoQ. NNPA at 3.37%, Vs 3.13% YoY and 2.35% QoQ.
City Union Bank Ltd.: NII at Rs. 428.5 crore, +2.2% YoY and -12.4% QoQ. Net Profit at Rs. 111.2 crore vs loss of Rs. 95.3 crore YoY and -34.6% QoQ. GNPA at 5.11x, Vs 4.09x YoY and 2.94x QoQ. NNPA at 2.97x, Vs 2.29x YoY and 1.47x QoQ.
Dilip Buildcon Ltd.: Net Revenue at Rs. 3135.5 crore, +14.9% YoY and +14.2% QoQ. EBITDA at Rs. 584.3 crore, +0.5% YoY and -7.3% QoQ. EBITDA Margin at 18.6%, -266 bps YoY and -432 bps QoQ. Net Profit at Rs. 186.2 crore, -2.6% YoY and +2.2% QoQ.
GMM Pfaudler Ltd.: Net Revenue at Rs. 458.6 crore, +248% YoY and +127.2% QoQ. EBITDA at Rs. 29.8 crore, +32.5% YoY and -29% QoQ. EBITDA Margin at 6.5%, -1056 bps YoY and -1429 bps QoQ. Net Profit at Rs. -5.8 crore, -149.6% YoY and -124.9% QoQ.
V-Mart Retail Ltd.: Net Revenue at Rs. 351.9 crore, +5.8% YoY and -25.1% QoQ. EBITDA at Rs. 33.6 crore, +20.5% YoY and -67.7% QoQ. EBITDA Margin at 9.5%, +117 bps YoY and +-1255 bps QoQ. Net Loss at Rs. 1.5 crore vs loss of Rs. 8.4 crore YoY and Profit of Rs. 47.9 crore QoQ.
Heidelberg Cement India Ltd.: Net Revenue at Rs. 600.0 crore, +17.7% YoY and +0.8% QoQ. EBITDA at Rs. 152.2 crore, +19.5% YoY and +26.6% QoQ. EBITDA Margin at 25.4%, +38 bps YoY and +517 bps QoQ. Net Profit at Rs. 140.0 crore, +111.2% YoY and +120% QoQ.
Nazara Technologies Ltd.: Net Revenue at Rs. 123.4 crore, +41.7% YoY and -5.4% QoQ. EBITDA at Rs. 9.3 crore, +1883.2% YoY and -63.6% QoQ. EBITDA Margin at 7.6%, +701 bps YoY and +-1209 bps QoQ. Net Profit at Rs. 4.2 crore vs loss of Rs. 7.0 crore YoY and -76.3% QoQ.
NCC Ltd.: Net Revenue at Rs. 2816.6 crore, +20.7% YoY and +32.4% QoQ. EBITDA at Rs. 305.7 crore, +6.5% YoY and +19.3% QoQ. EBITDA Margin at 10.9%, -144 bps YoY and -119 bps QoQ. Net Profit at Rs. 118.5 crore, +95.6% YoY and +52.1% QoQ.
Karur Vysya Bank Ltd.: NII at Rs. 612.6 crore, +3.7% YoY and +5% QoQ. Net Profit at Rs. 104.4 crore, +24.7% YoY and +201.4% QoQ. GNPA at 7.85x, Vs 8.68x YoY and 7.37x QoQ. NNPA at 3.41x, Vs 3.92x YoY and 2.55x QoQ.
Deepak Fertilisers & Petrochemicals Corporation Ltd.: Net Revenue at Rs. 1575.1 crore, +21.8% YoY and +8.8% QoQ. EBITDA at Rs. 273.1 crore, +128.4% YoY and +26% QoQ. EBITDA Margin at 17.3%, +809 bps YoY and +236 bps QoQ. Net Profit at Rs. 115.8 crore, +414.7% YoY and +30.2% QoQ.
Time Technoplast Ltd.: Net Revenue at Rs. 951.2 crore, +3.8% YoY and +13.9% QoQ. EBITDA at Rs. 129.1 crore, +9.3% YoY and +15% QoQ. EBITDA Margin at 13.6%, +68 bps YoY and +12 bps QoQ. Net Profit at Rs. 51.8 crore, +28.5% YoY and +30% QoQ.
ITD Cementation India Ltd.: Net Revenue at Rs. 983.9 crore, +33% YoY and +24.3% QoQ. EBITDA at Rs. 113.8 crore, +35.2% YoY and +60.4% QoQ. EBITDA Margin at 11.6%, +19 bps YoY and +261 bps QoQ. Net Profit at Rs. 52.6 crore vs loss of Rs. 5.5 crore YoY and +75.2% QoQ.
SMS Pharmaceuticals Ltd.: Net Revenue at Rs. 171.3 crore, +77.6% YoY and +15.1% QoQ. EBITDA at Rs. 41.1 crore, +185% YoY and +19.2% QoQ. EBITDA Margin at 24%, +905 bps YoY and +84 bps QoQ. Net Profit at Rs. 22.2 crore, +255.4% YoY and +21.2% QoQ.
Time Technoplast Ltd.: Net Revenue at Rs. 951.2 crore, +3.8% YoY and +13.9% QoQ. EBITDA at Rs. 129.1 crore, +9.3% YoY and +15% QoQ. EBITDA Margin at 13.6%, +68 bps YoY and +12 bps QoQ. Net Profit at Rs. 51.8 crore, +28.5% YoY and +30% QoQ.
ITD Cementation India Ltd.: Net Revenue at Rs. 983.9 crore, +33% YoY and +24.3% QoQ. EBITDA at Rs. 113.8 crore, +35.2% YoY and +60.4% QoQ. EBITDA Margin at 11.6%, +19 bps YoY and +261 bps QoQ. Net Profit at Rs. 52.6 crore vs loss of Rs. 5.5 crore YoY and +75.2% QoQ.
SMS Pharmaceuticals Ltd.: Net Revenue at Rs. 171.3 crore, +77.6% YoY and +15.1% QoQ. EBITDA at Rs. 41.1 crore, +185% YoY and +19.2% QoQ. EBITDA Margin at 24%, +905 bps YoY and +84 bps QoQ. Net Profit at Rs. 22.2 crore, +255.4% YoY and +21.2% QoQ.
*M&M Lines Up Rs 12,000 Crore To Revamp Vehicles, Regain Market Share*
Mahindra & Mahindra Ltd. will spend Rs 12,000 crore in the next three years towards launching and upgrading a range of passenger and commercial vehicles as it seeks to regain lost market share.
The capex earmarked will fuel the company’s plan of launching 23 new products in commercial and passenger vehicle segments in the next five years, Chief Financial Officer Manoj Bhat said on a call with analysts on May 28 after the company announced quarterly earnings. Once a market leader in the SUV segment, M&M’s share has plunged from 50% seven years ago to about 14% at present amid aggressive competition from Hyundai Motors India Ltd., Kia India Pvt. and Tata Motors Ltd. It has slipped to the fourth spot in the passenger vehicle segment.
Anish Shah, who recently took over as M&M’s chief executive officer, has set up a road map to revive growth. And the capex forecast offers a glimpse of the company’s focus for the next five years.
In the passenger vehicle business, the automaker will be spending Rs 9,000 crore towards strengthening its market share in the utility vehicle segment, more than a quarter of which will go towards developing electric vehicles,” Rajesh Jejurikar, executive director of auto and farm sectors at M&M, said on the analyst call. “We want to create a strong sophisticated SUV brand, and our endeavour will be to build a strong product portfolio,” Jejurikar said, adding that about nine launches are planned in the segment. The company will also spend to create a product portfolio in the electric vehicle segment and will scout for partnerships in areas of software, battery components, materials, among others.
The pipeline includes the five-door Thar, Scorpio, and the new Bolero which will be launched by 2026. Other launches such as XUV700, new XUV300 and SUVs codenamed W620 and V201, will also come with electric powertrain options. Besides, there will be two “born electric” or battery-powered models built from scratch that will debut in FY26.
The remaining Rs 3,000 crore will go towards the farm equipment sector to launch 14 new products across last-mile mobility, small commercial, and new urban pick-up ranges. The company will also invest to launch 37 new tractor models by 2026.
Additionally, M&M will invest Rs 5,000 crore in group companies and auto and farm subsidiaries. “These are directional investments, and if we don’t see a strong number of returns, we aren’t going to make it,” Shah said.
Mahindra & Mahindra Ltd. will spend Rs 12,000 crore in the next three years towards launching and upgrading a range of passenger and commercial vehicles as it seeks to regain lost market share.
The capex earmarked will fuel the company’s plan of launching 23 new products in commercial and passenger vehicle segments in the next five years, Chief Financial Officer Manoj Bhat said on a call with analysts on May 28 after the company announced quarterly earnings. Once a market leader in the SUV segment, M&M’s share has plunged from 50% seven years ago to about 14% at present amid aggressive competition from Hyundai Motors India Ltd., Kia India Pvt. and Tata Motors Ltd. It has slipped to the fourth spot in the passenger vehicle segment.
Anish Shah, who recently took over as M&M’s chief executive officer, has set up a road map to revive growth. And the capex forecast offers a glimpse of the company’s focus for the next five years.
In the passenger vehicle business, the automaker will be spending Rs 9,000 crore towards strengthening its market share in the utility vehicle segment, more than a quarter of which will go towards developing electric vehicles,” Rajesh Jejurikar, executive director of auto and farm sectors at M&M, said on the analyst call. “We want to create a strong sophisticated SUV brand, and our endeavour will be to build a strong product portfolio,” Jejurikar said, adding that about nine launches are planned in the segment. The company will also spend to create a product portfolio in the electric vehicle segment and will scout for partnerships in areas of software, battery components, materials, among others.
The pipeline includes the five-door Thar, Scorpio, and the new Bolero which will be launched by 2026. Other launches such as XUV700, new XUV300 and SUVs codenamed W620 and V201, will also come with electric powertrain options. Besides, there will be two “born electric” or battery-powered models built from scratch that will debut in FY26.
The remaining Rs 3,000 crore will go towards the farm equipment sector to launch 14 new products across last-mile mobility, small commercial, and new urban pick-up ranges. The company will also invest to launch 37 new tractor models by 2026.
Additionally, M&M will invest Rs 5,000 crore in group companies and auto and farm subsidiaries. “These are directional investments, and if we don’t see a strong number of returns, we aren’t going to make it,” Shah said.
TOWER TALK
May 29, 2021
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
May 29, 2021
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
*Jayant Organics’* Q4 EPS was fairly good at Rs. 6.48 v/s Rs. 2.52 and FY21 EPS of Rs. 11.20 v/s loss of Rs. 8.55 per share points to much better times ahead. Add.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Jindal SAW* declared highest ever quarterly sales and 461% higher net profit. It reduced debt in FY21 and interest cost fell to the lowest since FY14. This dark horse can give multi-bagger returns.
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 20
0 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
BS
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 20
0 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
BS